4.5 Article

Anti-metastatic Treatment in Colorectal Cancer: Targeting Signaling Pathways

Journal

CURRENT PHARMACEUTICAL DESIGN
Volume 19, Issue 5, Pages 841-863

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138161213804547277

Keywords

Colorectal cancer; HGF/Met pathway; metastasis; molecular therapeutics; Wnt/beta-catenin pathway

Funding

  1. Alexander von Humboldt Foundation

Ask authors/readers for more resources

Colorectal cancer is one of the most common cancers worldwide and one of the leading causes of cancer-related death in the Western world. Tumor progression towards metastasis affects a large number of patients with colorectal cancer and seriously affects their clinical outcome. Therefore, considerable effort has been made towards the development of therapeutic strategies that can decrease or prevent colorectal cancer metastasis. Standard treatment of metastatic colorectal cancer with chemotherapy has been improved in the last 10 years by the addition of new targeted agents. The currently used antibodies bevacizumab, cetuximab and panitumumab target the VEGF and EGFR signaling pathways, which are crucial for tumor progression and metastasis. These antibodies have shown relevant efficacy in both first- and second-line treatment of metastatic colorectal cancer. Additionally, other signaling pathways, including the Wnt and HGF/Met pathways, have a well-established role in colorectal cancer progression and metastasis and constitute, therefore, promising targets for new therapeutic approaches. Several new drugs targeting these pathways, including different antibodies and small-molecule tyrosine kinase inhibitors, are currently being developed and tested in clinical trials. In this review, we summarize the new developments in this field, focusing on the inhibitors that show more promising results for use in colorectal cancer patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Obesity, colorectal cancer and MACC1 expression: A possible novel molecular association

Ina Baehr, Lina Jaeschke, Katharina Nimptsch, Juergen Janke, Pia Herrmann, Dennis Kobelt, Heike Kielstein, Tobias Pischon, Ulrike Stein

Summary: This study found higher plasma MACC1 levels in obese individuals, which were positively correlated with body fat mass and body mass index. The MLU study showed that reducing body fat mass through dietary intervention and physical exercise decreased MACC1 expression levels. Obese Wistar rats with diet-induced obesity and colon cancer exhibited significantly higher MACC1 levels compared to non-obese rats.

INTERNATIONAL JOURNAL OF ONCOLOGY (2022)

Article Oncology

Real-world evidence for preventive effects of statins on cancer incidence: A trans-Atlantic analysis

Bjoern-O Gohlke, Fabian Zincke, Andreas Eckert, Dennis Kobelt, Saskia Preissner, Juliane Maria Liebeskind, Nikolas Gunkel, Kerstin Putzker, Joe Lewis, Sally Preissner, Benedikt Kortum, Wolfgang Walther, Cameron Mura, Philip E. Bourne, Ulrike Stein, Robert Preissner

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

Article Oncology

Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarker

Felicitas Schmid, Mathias Dahlmann, Hanna Roehrich, Dennis Kobelt, Jens Hoffmann, Susen Burock, Wolfgang Walther, Ulrike Stein

Summary: The study identified S100P as a transcriptional target gene of MACC1, showing that the expression of S100P increases the metastatic potential of CRC cells in vitro and in vivo and serves as a prognostic biomarker for metastasis-free survival of CRC patients, highlighting novel therapeutic interventions targeting S100P.

BRITISH JOURNAL OF CANCER (2022)

Article Oncology

Elevated MACC1 Expression in Colorectal Cancer Is Driven by Chromosomal Instability and Is Associated with Molecular Subtype and Worse Patient Survival

Vincent Vuaroqueaux, Alexandra Musch, Dennis Kobelt, Thomas Risch, Pia Herrmann, Susen Burock, Anne-Lise Peille, Marie-Laure Yaspo, Heinz-Herbert Fiebig, Ulrike Stein

Summary: This study investigates the contribution of chromosomal instability and somatic copy number alterations (SCNA) to the dysregulation of MACC1 in colorectal cancer (CRC). The findings suggest that elevated MACC1 expression is largely driven by chromosomal instability (CIN), SCNA gains, and molecular subtypes, and it has prognostic and predictive impacts on metastasis and survival. These insights could potentially serve as a basis for personalized treatment decisions.

CANCERS (2022)

Article Oncology

Inhibition of MACC1-Induced Metastasis in Esophageal and Gastric Adenocarcinomas

Christoph Treese, Jessica Werchan, Moritz von Winterfeld, Erika Berg, Michael Hummel, Lena Timm, Beate Rau, Ole Daberkow, Wolfgang Walther, Severin Daum, Dennis Kobelt, Ulrike Stein

Summary: MACC1 plays a negative prognostic role in esophageal and gastric adenocarcinomas and its effect can be inhibited by selumetinib.

CANCERS (2022)

Article Cell Biology

S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus

Christoph Treese, Kimberly Hartl, Michelle Potzsch, Matthias Dahlmann, Moritz von Winterfeld, Erika Berg, Michael Hummel, Lena Timm, Beate Rau, Wolfgang Walther, Severin Daum, Dennis Kobelt, Ulrike Stein

Summary: S100A4 plays a key role in the metastasis of adenocarcinoma of the gastroesophageal junction and stomach, and its high expression is significantly correlated with poor prognosis and metastasis development.

CELLS (2022)

Article Oncology

Core-Clock Genes Regulate Proliferation and Invasion via a Reciprocal Interplay with MACC1 in Colorectal Cancer Cells

Alireza Basti, Deeksha Malhan, Malti Dumbani, Mathias Dahlmann, Ulrike Stein, Angela Relogio

Summary: The study investigates the interaction between the biological clock and metastasis-associated gene MACC1 in colorectal cancer (CRC). Results show a reciprocal interplay between the circadian clock and MACC1, suggesting a potential regulation of CRC invasiveness through the circadian clock.

CANCERS (2022)

Article Oncology

MACC1-Induced Collective Migration Is Promoted by Proliferation Rather Than Single Cell Biomechanics

Tim Hohmann, Urszula Hohmann, Mathias Dahlmann, Dennis Kobelt, Ulrike Stein, Faramarz Dehghani

Summary: High expression of MACC1 in colon cancer is associated with metastasis, tumor cell migration, and increased proliferation. This study found that MACC1 expression promotes collective migration, which is caused by increased proliferation, without affecting single cell biomechanics. Targeting proliferation may offer additional effects on cell migration in high-MACC1-expressing tumors.

CANCERS (2022)

Article Oncology

Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas

J. J. Staudacher, Alexander Arnold, A. A. Kuehl, M. Poetzsch, S. Daum, M. Winterfeld, E. Berg, M. Hummel, B. Rau, U. Stein, C. Treese

Summary: This study aimed to investigate the prognostic role of activin tumor protein expression in esophageal and gastric adenocarcinomas. The results showed that higher levels of activin subunits were associated with lower cancer stage and longer overall survival. Furthermore, tumors with higher activin subunit expression also had higher CD4(+) T-cell infiltration, and the longer overall survival effect was only observed in tumors with high CD4(+) T-cell infiltration.

BMC CANCER (2022)

Review Biochemistry & Molecular Biology

Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges

Monica A. Kamal, Yasmine M. Mandour, Mostafa K. Abd El-Aziz, Ulrike Stein, Hend M. El Tayebi

Summary: Liver cancer is a common and limitedly treated type of cancer. Recently, new target proteins and pathways have been discovered, leading to the design of new drugs. This review provides an overview of these targets and compounds.

MOLECULES (2022)

Article Biochemistry & Molecular Biology

Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis

Benedikt Kortuem, Harikrishnan Radhakrishnan, Fabian Zincke, Christoph Sachse, Susen Burock, Ulrich Keilholz, Mathias Dahlmann, Wolfgang Walther, Gunnar Dittmar, Dennis Kobelt, Ulrike Stein

Summary: Colorectal cancer is the second most common malignant disease worldwide, and metastasis is the main cause of death in CRC patients. The study identified MACC1 and S100A4 as key genes promoting CRC metastasis and found repositioned drugs that can inhibit metastasis.

ONCOGENE (2022)

Article Oncology

Radiofrequency Electromagnetic Fields Cause Non-Temperature-Induced Physical and Biological Effects in Cancer Cells

Peter Wust, Paraskevi D. Veltsista, Eva Oberacker, Prabhusrinivas Yavvari, Wolfgang Walther, Olof Bengtsson, Anja Sterner-Kock, Marie Weinhart, Florian Heyd, Patricia Grabowski, Sebastian Stintzing, Wolfgang Heinrich, Ulrike Stein, Pirus Ghadjar

Summary: Adding amplitude modulation to radiofrequency waves can enhance non-temperature-induced anticancer effects. The study demonstrated that radiofrequency electromagnetic fields, along with amplitude modulation, can effectively inhibit tumor growth and enhance apoptosis, with the latter being correlated with cell membrane stiffness.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Cantharidin and Its Analogue Norcantharidin Inhibit Metastasis-Inducing Genes S100A4 and MACC1

Paul Curtis Schoepe, Viktoria Zinnow, Muhammad Ahtisham Ishfaq, Janice Smith, Pia Herrmann, Robert H. Shoemaker, Wolfgang Walther, Ulrike Stein

Summary: Colorectal cancer is a prevalent and deadly cancer worldwide, with metastasis being responsible for most deaths. Biomarkers like S100A4 and MACC1 help identify high-risk patients for metastasis. Cantharidin and norcantharidin, natural compounds extracted from blister beetles, have shown anti-cancer and anti-metastatic effects in various cancers. This study demonstrates that cantharidin and norcantharidin inhibit the expression of S100A4 and MACC1, suggesting their potential as promising compounds for personalized anti-metastatic therapy in cancer patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Nutrition & Dietetics

MACC1-Dependent Antitumor Effect of Curcumin in Colorectal Cancer

Nazli Guellue, Janice Smith, Pia Herrmann, Ulrike Stein

Summary: This study investigated the effect of curcumin, a natural product, on the expression and tumor-promoting pathways of MACC1, a metastasis-associated gene in colorectal cancer (CRC). The findings showed that curcumin reduced MACC1 expression, restricted MACC1-induced cell proliferation, and decreased MACC1-induced cell motility, crucial for tumor dissemination. Additionally, the study demonstrated the MACC1-dependent effect of curcumin on clonogenicity and wound healing, which had not been previously reported.

NUTRIENTS (2022)

Article Gastroenterology & Hepatology

Immunohistochemical Analysis of Nicotinamide Phosphoribosyltransferase Expression in Gastric and Esophageal Adenocarcinoma (AEG)

Alexander Arnold, Moritz von Winterfeld, Erika Berg, Michael Hummel, Beate Rau, Felix Krenzien, Ulrike Stein, Christoph Treese

Summary: The study found that only a minority of tumors in AEG/S tissues had high expression of NAMPT, and that NAMPT expression was more frequent in older patients, although not significantly correlated with survival.

GASTROINTESTINAL DISORDERS (2022)

No Data Available